Drug Database
L04AB02 infliximab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Flixabi 100 mg powder for concentrate for solution for infusion
- POM Inflectra 100 mg powder for concentrate for solution for infusion
- POM Remicade 100mg powder for concentrate for solution for infusion
- POM Remicade 100mg powder for concentrate for solution for infusion (Northern Ireland)
- POM Remsima 100 mg powder for concentrate for solution for infusion
- POM Remsima SC 120mg solution for injection in PFP and PFS
- POM Remsima SC 120mg solution for injection in PFS
- POM Zessly 100 mg powder for concentrate for solution for infusion ▼
- POM Zessly 100 mg powder for concentrate for solution for infusion (Great Britain) ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).